Annual Income Statements for Abacus Life
This table shows Abacus Life's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Abacus Life
This table shows Abacus Life's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Net Income / (Loss) Attributable to Common Shareholders |
|
9.99 |
7.63 |
8.09 |
6.75 |
0.90 |
-6.22 |
-1.35 |
0.77 |
-5.13 |
-18 |
4.64 |
Consolidated Net Income / (Loss) |
|
10 |
7.56 |
7.62 |
6.72 |
1.05 |
-6.36 |
-1.28 |
0.65 |
-5.28 |
-19 |
5.40 |
Net Income / (Loss) Continuing Operations |
|
11 |
8.69 |
7.82 |
6.96 |
-0.29 |
-5.45 |
-1.06 |
0.79 |
-4.10 |
-21 |
5.40 |
Total Pre-Tax Income |
|
11 |
8.02 |
6.97 |
7.91 |
6.30 |
-11 |
-0.10 |
2.41 |
-5.54 |
-16 |
7.73 |
Total Revenue |
|
12 |
26 |
11 |
12 |
23 |
21 |
22 |
29 |
29 |
32 |
44 |
Net Interest Income / (Expense) |
|
0.00 |
-0.04 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
Total Interest Income |
|
0.00 |
-0.00 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
Total Interest Expense |
|
0.00 |
0.04 |
0.00 |
0.00 |
0.00 |
- |
0.00 |
0.00 |
0.00 |
- |
0.00 |
Total Non-Interest Income |
|
12 |
26 |
11 |
12 |
23 |
21 |
22 |
29 |
29 |
32 |
44 |
Other Non-Interest Income |
|
0.76 |
- |
0.61 |
0.71 |
4.39 |
-0.50 |
1.91 |
2.27 |
2.36 |
2.57 |
44 |
Total Non-Interest Expense |
|
0.84 |
16 |
2.86 |
3.13 |
15 |
21 |
19 |
22 |
21 |
50 |
23 |
Marketing Expense |
|
0.01 |
- |
0.73 |
0.68 |
1.70 |
1.79 |
1.93 |
2.55 |
2.17 |
2.41 |
2.62 |
Other Operating Expenses |
|
0.58 |
15 |
2.25 |
3.12 |
11 |
19 |
17 |
18 |
18 |
43 |
16 |
Depreciation Expense |
|
0.00 |
- |
0.00 |
0.00 |
1.69 |
1.71 |
1.68 |
1.75 |
1.75 |
2.73 |
4.76 |
Other Special Charges |
|
0.25 |
- |
-0.13 |
-0.67 |
0.31 |
-0.88 |
-1.16 |
0.36 |
-0.42 |
1.46 |
-0.27 |
Nonoperating Income / (Expense), net |
|
0.04 |
- |
-0.56 |
-0.46 |
-3.54 |
-9.06 |
-2.36 |
-4.36 |
-12 |
0.56 |
-13 |
Income Tax Expense |
|
0.35 |
- |
-0.66 |
1.18 |
1.71 |
-0.77 |
1.17 |
1.76 |
-0.25 |
2.80 |
2.33 |
Net Income / (Loss) Attributable to Noncontrolling Interest |
|
0.36 |
- |
-0.46 |
-0.03 |
0.15 |
-0.14 |
0.07 |
-0.12 |
-0.16 |
-0.75 |
0.76 |
Basic Earnings per Share |
|
$0.20 |
- |
$0.16 |
$0.13 |
$0.01 |
($0.13) |
($0.02) |
$0.01 |
($0.07) |
($0.26) |
$0.05 |
Weighted Average Basic Shares Outstanding |
|
50.37M |
50.37M |
50.37M |
50.51M |
63.35M |
56.95M |
63.03M |
63.85M |
74.69M |
70.76M |
96.19M |
Diluted Earnings per Share |
|
$0.20 |
- |
$0.16 |
$0.13 |
$0.01 |
($0.14) |
($0.02) |
$0.01 |
($0.07) |
($0.26) |
$0.05 |
Weighted Average Diluted Shares Outstanding |
|
50.37M |
50.37M |
50.37M |
50.51M |
63.35M |
57.77M |
63.03M |
67.16M |
74.69M |
70.76M |
97.50M |
Weighted Average Basic & Diluted Shares Outstanding |
|
18.34M |
0.00 |
11.48M |
62.96M |
63.35M |
63.69M |
63.93M |
74.65M |
74.68M |
96.85M |
96.85M |
Annual Cash Flow Statements for Abacus Life
This table details how cash moves in and out of Abacus Life's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
Metric |
2022 |
2023 |
2024 |
Net Change in Cash & Equivalents |
30 |
-4.46 |
106 |
Net Cash From Operating Activities |
11 |
-64 |
-209 |
Net Cash From Continuing Operating Activities |
11 |
-64 |
-209 |
Net Income / (Loss) Continuing Operations |
32 |
9.03 |
-25 |
Consolidated Net Income / (Loss) |
32 |
9.03 |
-25 |
Depreciation Expense |
0.00 |
3.41 |
7.91 |
Amortization Expense |
0.00 |
0.04 |
0.94 |
Non-Cash Adjustments to Reconcile Net Income |
-3.72 |
-6.80 |
0.79 |
Changes in Operating Assets and Liabilities, net |
-18 |
-70 |
-194 |
Net Cash From Investing Activities |
-3.70 |
2.24 |
-4.96 |
Net Cash From Continuing Investing Activities |
-3.70 |
2.24 |
-4.96 |
Purchase of Property, Leasehold Improvements and Equipment |
0.00 |
-0.19 |
-0.79 |
Purchase of Investment Securities |
-0.80 |
-0.35 |
-3.65 |
Other Investing Activities, net |
-2.90 |
2.78 |
-0.52 |
Net Cash From Financing Activities |
23 |
57 |
320 |
Net Cash From Continuing Financing Activities |
23 |
57 |
320 |
Issuance of Debt |
30 |
124 |
198 |
Issuance of Common Equity |
- |
0.00 |
182 |
Repayment of Debt |
0.00 |
-26 |
-32 |
Repurchase of Common Equity |
0.00 |
-1.28 |
-11 |
Payment of Dividends |
-7.07 |
-24 |
-1.16 |
Other Financing Activities, Net |
0.00 |
-16 |
-16 |
Cash Interest Paid |
0.00 |
4.04 |
12 |
Cash Income Taxes Paid |
0.00 |
0.15 |
2.15 |
Quarterly Cash Flow Statements for Abacus Life
This table details how cash moves in and out of Abacus Life's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Net Change in Cash & Equivalents |
|
1.00 |
26 |
-10 |
0.89 |
16 |
-11 |
40 |
26 |
-72 |
113 |
-88 |
Net Cash From Operating Activities |
|
-1.64 |
17 |
-17 |
-21 |
-12 |
-14 |
2.27 |
-67 |
-52 |
-92 |
-62 |
Net Cash From Continuing Operating Activities |
|
-1.64 |
17 |
-17 |
-21 |
-12 |
-14 |
2.27 |
-67 |
-52 |
-92 |
-62 |
Net Income / (Loss) Continuing Operations |
|
10 |
10 |
7.62 |
6.72 |
1.05 |
-6.36 |
-1.28 |
0.65 |
-5.28 |
-19 |
5.40 |
Consolidated Net Income / (Loss) |
|
10 |
10 |
7.62 |
6.72 |
1.05 |
-6.36 |
-1.28 |
0.65 |
-5.28 |
-19 |
5.40 |
Depreciation Expense |
|
0.00 |
0.00 |
0.00 |
0.00 |
1.69 |
1.71 |
1.68 |
1.75 |
1.75 |
2.73 |
4.76 |
Amortization Expense |
|
- |
- |
0.00 |
- |
0.13 |
-0.09 |
0.09 |
0.36 |
0.19 |
0.30 |
0.49 |
Non-Cash Adjustments to Reconcile Net Income |
|
-57 |
61 |
-1.02 |
-0.45 |
-4.75 |
-0.58 |
5.39 |
-5.93 |
-3.02 |
4.34 |
-71 |
Changes in Operating Assets and Liabilities, net |
|
45 |
-54 |
-24 |
-27 |
-9.99 |
-8.49 |
-3.63 |
-64 |
-46 |
-80 |
-1.74 |
Net Cash From Investing Activities |
|
-1.68 |
-1.77 |
-1.00 |
-6.06 |
9.63 |
-0.33 |
-0.01 |
-0.71 |
-0.45 |
-3.79 |
-3.74 |
Net Cash From Continuing Investing Activities |
|
-1.68 |
-1.77 |
-1.00 |
-6.06 |
9.63 |
-0.33 |
-0.01 |
-0.71 |
-0.45 |
-3.79 |
-3.74 |
Purchase of Property, Leasehold Improvements and Equipment |
|
- |
- |
0.00 |
- |
-0.10 |
-0.09 |
-0.16 |
-0.19 |
-0.24 |
-0.19 |
-0.22 |
Purchase of Investment Securities |
|
- |
-0.55 |
-0.15 |
-0.15 |
-0.05 |
- |
-0.09 |
-0.11 |
-0.10 |
-3.35 |
-3.52 |
Net Cash From Financing Activities |
|
4.33 |
11 |
8.05 |
28 |
18 |
3.08 |
38 |
93 |
-19 |
208 |
-23 |
Net Cash From Continuing Financing Activities |
|
4.33 |
11 |
8.05 |
28 |
18 |
3.08 |
38 |
93 |
-19 |
208 |
-23 |
Issuance of Debt |
|
3.44 |
17 |
8.05 |
52 |
27 |
37 |
43 |
9.03 |
15 |
132 |
16 |
Repayment of Debt |
|
- |
- |
- |
- |
- |
-26 |
- |
- |
- |
- |
-39 |
Repurchase of Common Equity |
|
- |
- |
0.00 |
- |
- |
-1.28 |
-7.52 |
-3.22 |
- |
- |
0.00 |
Other Financing Activities, Net |
|
1.82 |
-2.50 |
0.00 |
-0.69 |
-8.74 |
-6.10 |
2.14 |
-3.19 |
-1.68 |
-13 |
-0.47 |
Cash Interest Paid |
|
- |
- |
0.00 |
0.77 |
0.56 |
2.71 |
1.69 |
2.94 |
3.22 |
3.76 |
5.37 |
Cash Income Taxes Paid |
|
- |
- |
0.00 |
- |
- |
0.15 |
0.00 |
2.69 |
- |
-0.55 |
0.00 |
Annual Balance Sheets for Abacus Life
This table presents Abacus Life's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
Metric |
2022 |
2023 |
2024 |
Total Assets |
59 |
332 |
874 |
Cash and Due from Banks |
30 |
26 |
132 |
Trading Account Securities |
1.89 |
3.45 |
2.21 |
Loans and Leases, Net of Allowance |
0.00 |
0.00 |
0.00 |
Customer and Other Receivables |
0.00 |
1.01 |
1.53 |
Premises and Equipment, Net |
0.02 |
0.40 |
1.03 |
Goodwill |
0.00 |
140 |
238 |
Intangible Assets |
0.00 |
30 |
80 |
Other Assets |
27 |
131 |
419 |
Total Liabilities & Shareholders' Equity |
59 |
332 |
874 |
Total Liabilities |
31 |
168 |
451 |
Interest Bearing Deposits |
0.00 |
0.51 |
2.47 |
Short-Term Debt |
0.04 |
13 |
38 |
Accrued Interest Payable |
0.96 |
5.22 |
7.14 |
Other Short-Term Payables |
0.31 |
4.57 |
14 |
Long-Term Debt |
28 |
127 |
342 |
Other Long-Term Liabilities |
1.39 |
18 |
46 |
Commitments & Contingencies |
0.00 |
0.00 |
0.00 |
Total Equity & Noncontrolling Interests |
28 |
164 |
423 |
Total Preferred & Common Equity |
27 |
164 |
424 |
Preferred Stock |
0.00 |
0.00 |
0.00 |
Total Common Equity |
27 |
164 |
424 |
Common Stock |
0.71 |
200 |
494 |
Retained Earnings |
25 |
-35 |
-58 |
Treasury Stock |
0.00 |
-1.28 |
-12 |
Accumulated Other Comprehensive Income / (Loss) |
1.05 |
0.11 |
0.00 |
Noncontrolling Interest |
0.90 |
0.14 |
-0.86 |
Quarterly Balance Sheets for Abacus Life
This table presents Abacus Life's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
Metric |
|
Q3 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Total Assets |
|
100 |
30 |
277 |
304 |
377 |
484 |
477 |
857 |
Cash and Due from Banks |
|
1.67 |
0.06 |
21 |
37 |
65 |
91 |
19 |
44 |
Trading Account Securities |
|
- |
- |
1.00 |
1.00 |
4.66 |
5.17 |
4.20 |
2.74 |
Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Customer and Other Receivables |
|
- |
- |
0.08 |
1.00 |
- |
1.17 |
1.28 |
1.67 |
Premises and Equipment, Net |
|
- |
- |
0.18 |
0.26 |
0.55 |
0.69 |
0.89 |
1.18 |
Goodwill |
|
- |
- |
140 |
140 |
140 |
140 |
140 |
238 |
Intangible Assets |
|
- |
- |
33 |
31 |
28 |
26 |
25 |
75 |
Other Assets |
|
0.31 |
0.18 |
82 |
92 |
138 |
219 |
287 |
494 |
Total Liabilities & Shareholders' Equity |
|
100 |
30 |
277 |
304 |
377 |
484 |
477 |
857 |
Total Liabilities |
|
30 |
20 |
117 |
138 |
211 |
227 |
219 |
421 |
Interest Bearing Deposits |
|
- |
- |
0.98 |
0.35 |
0.67 |
1.44 |
0.92 |
0.60 |
Short-Term Debt |
|
4.92 |
5.58 |
0.40 |
0.00 |
16 |
46 |
14 |
118 |
Accrued Interest Payable |
|
7.94 |
10 |
1.12 |
0.89 |
2.32 |
2.47 |
5.14 |
3.27 |
Other Short-Term Payables |
|
- |
- |
11 |
4.22 |
5.19 |
5.71 |
3.66 |
8.83 |
Long-Term Debt |
|
- |
- |
91 |
119 |
170 |
151 |
167 |
238 |
Other Long-Term Liabilities |
|
17 |
4.15 |
12 |
14 |
17 |
20 |
29 |
52 |
Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Redeemable Noncontrolling Interest |
|
98 |
29 |
- |
- |
- |
- |
- |
5.00 |
Total Equity & Noncontrolling Interests |
|
-27 |
-20 |
160 |
166 |
165 |
257 |
258 |
431 |
Total Preferred & Common Equity |
|
-27 |
-20 |
160 |
166 |
165 |
257 |
258 |
431 |
Preferred Stock |
|
0.00 |
0.00 |
- |
- |
0.00 |
0.00 |
0.00 |
0.00 |
Total Common Equity |
|
-27 |
-20 |
160 |
166 |
165 |
257 |
258 |
431 |
Common Stock |
|
0.03 |
0.00 |
189 |
194 |
210 |
303 |
310 |
496 |
Retained Earnings |
|
-28 |
-20 |
-29 |
-29 |
-36 |
-35 |
-40 |
-53 |
Treasury Stock |
|
- |
- |
- |
- |
-8.81 |
-12 |
-12 |
-12 |
Noncontrolling Interest |
|
- |
- |
0.36 |
0.29 |
0.21 |
0.08 |
-0.09 |
-0.10 |
Annual Metrics And Ratios for Abacus Life
This table displays calculated financial ratios and metrics derived from Abacus Life's official financial filings.
Metric |
2022 |
2023 |
2024 |
Growth Metrics |
- |
- |
- |
Revenue Growth |
74,422,038.71% |
43.91% |
68.56% |
EBITDA Growth |
118.64% |
-21.42% |
-71.15% |
EBIT Growth |
121.88% |
-31.25% |
-103.68% |
NOPAT Growth |
106.59% |
-36.58% |
-103.00% |
Net Income Growth |
104.47% |
-72.10% |
-375.81% |
EPS Growth |
0.00% |
-74.60% |
-312.50% |
Operating Cash Flow Growth |
964.76% |
-698.92% |
-226.04% |
Free Cash Flow Firm Growth |
0.00% |
-176.97% |
-120.93% |
Invested Capital Growth |
-82.27% |
438.44% |
164.61% |
Revenue Q/Q Growth |
127.42% |
-7.10% |
16.07% |
EBITDA Q/Q Growth |
18.50% |
-23.43% |
-59.18% |
EBIT Q/Q Growth |
19.04% |
-29.43% |
-107.37% |
NOPAT Q/Q Growth |
22.44% |
-28.92% |
-120.21% |
Net Income Q/Q Growth |
23.20% |
-60.65% |
-103.03% |
EPS Q/Q Growth |
0.00% |
0.00% |
-54.55% |
Operating Cash Flow Q/Q Growth |
258.75% |
-93.23% |
-59.25% |
Free Cash Flow Firm Q/Q Growth |
0.00% |
-25.80% |
-232.54% |
Invested Capital Q/Q Growth |
-25.25% |
6.66% |
83.34% |
Profitability Metrics |
- |
- |
- |
EBITDA Margin |
76.07% |
41.53% |
7.11% |
EBIT Margin |
76.06% |
36.33% |
-0.79% |
Profit (Net Income) Margin |
70.19% |
13.61% |
-22.26% |
Tax Burden Percent |
97.33% |
86.02% |
128.22% |
Interest Burden Percent |
94.82% |
43.53% |
2,187.69% |
Effective Tax Rate |
2.67% |
13.98% |
0.00% |
Return on Invested Capital (ROIC) |
17.47% |
11.52% |
-0.11% |
ROIC Less NNEP Spread (ROIC-NNEP) |
15.21% |
-2.42% |
-9.45% |
Return on Net Nonoperating Assets (RNNOA) |
1.31% |
-2.12% |
-8.37% |
Return on Equity (ROE) |
18.78% |
9.40% |
-8.48% |
Cash Return on Invested Capital (CROIC) |
157.22% |
-125.83% |
-90.40% |
Operating Return on Assets (OROA) |
17.33% |
12.34% |
-0.15% |
Return on Assets (ROA) |
15.99% |
4.62% |
-4.13% |
Return on Common Equity (ROCE) |
-0.05% |
9.35% |
-8.50% |
Return on Equity Simple (ROE_SIMPLE) |
118.85% |
5.51% |
-5.87% |
Net Operating Profit after Tax (NOPAT) |
33 |
21 |
-0.62 |
NOPAT Margin |
70.92% |
31.25% |
-0.56% |
Net Nonoperating Expense Percent (NNEP) |
2.26% |
13.94% |
9.33% |
SG&A Expenses to Revenue |
5.63% |
7.39% |
8.10% |
Operating Expenses to Revenue |
23.94% |
63.67% |
100.79% |
Earnings before Interest and Taxes (EBIT) |
35 |
24 |
-0.89 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
35 |
28 |
7.96 |
Valuation Ratios |
- |
- |
- |
Price to Book Value (P/BV) |
6.84 |
3.73 |
1.38 |
Price to Tangible Book Value (P/TBV) |
6.84 |
0.00 |
5.51 |
Price to Revenue (P/Rev) |
4.04 |
9.22 |
5.22 |
Price to Earnings (P/E) |
5.88 |
64.30 |
0.00 |
Dividend Yield |
0.00% |
0.00% |
0.00% |
Earnings Yield |
17.00% |
1.56% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
3.29 |
2.39 |
1.04 |
Enterprise Value to Revenue (EV/Rev) |
4.02 |
10.94 |
7.44 |
Enterprise Value to EBITDA (EV/EBITDA) |
5.29 |
26.34 |
104.64 |
Enterprise Value to EBIT (EV/EBIT) |
5.29 |
30.11 |
0.00 |
Enterprise Value to NOPAT (EV/NOPAT) |
5.67 |
35.00 |
0.00 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
17.35 |
0.00 |
0.00 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
0.63 |
0.00 |
0.00 |
Leverage & Solvency |
- |
- |
- |
Debt to Equity |
1.01 |
0.85 |
0.90 |
Long-Term Debt to Equity |
1.00 |
0.77 |
0.81 |
Financial Leverage |
0.09 |
0.87 |
0.89 |
Leverage Ratio |
1.17 |
2.03 |
2.05 |
Compound Leverage Factor |
1.11 |
0.89 |
44.92 |
Debt to Total Capital |
50.12% |
46.01% |
47.36% |
Short-Term Debt to Total Capital |
0.07% |
4.29% |
4.78% |
Long-Term Debt to Total Capital |
50.05% |
41.72% |
42.58% |
Preferred Equity to Total Capital |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
1.59% |
0.05% |
-0.11% |
Common Equity to Total Capital |
48.28% |
53.94% |
52.75% |
Debt to EBITDA |
0.81 |
5.07 |
47.85 |
Net Debt to EBITDA |
-0.05 |
4.14 |
31.27 |
Long-Term Debt to EBITDA |
0.80 |
4.60 |
43.02 |
Debt to NOPAT |
0.86 |
6.74 |
-612.43 |
Net Debt to NOPAT |
-0.05 |
5.50 |
-400.24 |
Long-Term Debt to NOPAT |
0.86 |
6.11 |
-550.63 |
Noncontrolling Interest Sharing Ratio |
100.29% |
0.54% |
-0.12% |
Liquidity Ratios |
- |
- |
- |
Cash Flow Metrics |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
295 |
-227 |
-501 |
Operating Cash Flow to CapEx |
0.00% |
-33,765.51% |
-26,558.24% |
Free Cash Flow to Firm to Interest Expense |
6,882.25 |
0.00 |
0.00 |
Operating Cash Flow to Interest Expense |
249.85 |
0.00 |
0.00 |
Operating Cash Flow Less CapEx to Interest Expense |
249.85 |
0.00 |
0.00 |
Efficiency Ratios |
- |
- |
- |
Asset Turnover |
0.23 |
0.34 |
0.19 |
Fixed Asset Turnover |
0.00 |
316.70 |
157.00 |
Capital & Investment Metrics |
- |
- |
- |
Invested Capital |
56 |
304 |
804 |
Invested Capital Turnover |
0.25 |
0.37 |
0.20 |
Increase / (Decrease) in Invested Capital |
-262 |
247 |
500 |
Enterprise Value (EV) |
186 |
726 |
833 |
Market Capitalization |
186 |
612 |
585 |
Book Value per Share |
$1.49 |
$2.59 |
$5.68 |
Tangible Book Value per Share |
$1.49 |
($0.09) |
$1.42 |
Total Capital |
56 |
304 |
804 |
Total Debt |
28 |
140 |
381 |
Total Long-Term Debt |
28 |
127 |
342 |
Net Debt |
-1.76 |
114 |
249 |
Capital Expenditures (CapEx) |
0.00 |
0.19 |
0.79 |
Net Nonoperating Expense (NNE) |
0.34 |
12 |
24 |
Net Nonoperating Obligations (NNO) |
28 |
140 |
381 |
Total Depreciation and Amortization (D&A) |
0.00 |
3.45 |
8.85 |
Earnings Adjustments |
- |
- |
- |
Adjusted Basic Earnings per Share |
$0.00 |
$0.00 |
($0.34) |
Adjusted Weighted Average Basic Shares Outstanding |
32.26M |
0.00 |
70.76M |
Adjusted Diluted Earnings per Share |
$0.00 |
$0.00 |
($0.34) |
Adjusted Weighted Average Diluted Shares Outstanding |
32.26M |
0.00 |
70.76M |
Adjusted Basic & Diluted Earnings per Share |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
0.00 |
0.00 |
96.85M |
Normalized Net Operating Profit after Tax (NOPAT) |
34 |
20 |
-0.46 |
Normalized NOPAT Margin |
73.12% |
29.48% |
-0.41% |
Pre Tax Income Margin |
72.12% |
15.82% |
-17.36% |
Debt Service Ratios |
- |
- |
- |
EBIT to Interest Expense |
819.98 |
0.00 |
0.00 |
NOPAT to Interest Expense |
764.60 |
0.00 |
0.00 |
EBIT Less CapEx to Interest Expense |
819.98 |
0.00 |
0.00 |
NOPAT Less CapEx to Interest Expense |
764.60 |
0.00 |
0.00 |
Payout Ratios |
- |
- |
- |
Dividend Payout Ratio |
21.82% |
263.34% |
-4.68% |
Augmented Payout Ratio |
21.82% |
277.54% |
-47.78% |
Quarterly Metrics And Ratios for Abacus Life
This table displays calculated financial ratios and metrics derived from Abacus Life's official financial filings.
Metric |
|
Q3 2022 |
Q4 2022 |
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Revenue Growth |
|
62,578,810.53% |
99,433,800.00% |
58,756,900.00% |
39.70% |
96.10% |
-19.64% |
105.22% |
149.56% |
25.79% |
52.14% |
105.42% |
EBITDA Growth |
|
8.76% |
140.70% |
-17.68% |
61.32% |
-6.57% |
-90.07% |
-45.00% |
4.79% |
-3.49% |
-1,741.53% |
552.43% |
EBIT Growth |
|
8.75% |
149.47% |
-17.40% |
61.34% |
-23.11% |
-107.40% |
-67.99% |
-19.70% |
-5.46% |
-2,538.99% |
833.23% |
NOPAT Growth |
|
1.48% |
446.52% |
-11.85% |
36.58% |
-30.51% |
-114.07% |
-80.85% |
-74.27% |
-33.10% |
-939.75% |
830.79% |
Net Income Growth |
|
-3.79% |
417.21% |
-18.75% |
32.19% |
-89.85% |
-184.17% |
-116.73% |
-90.31% |
-602.85% |
-198.66% |
523.30% |
EPS Growth |
|
0.00% |
0.00% |
0.00% |
44.44% |
-95.00% |
0.00% |
-112.50% |
-92.31% |
-800.00% |
-85.71% |
350.00% |
Operating Cash Flow Growth |
|
-302.73% |
5,117.48% |
-6,093.54% |
-369.37% |
-621.86% |
-180.82% |
113.04% |
-218.39% |
-340.54% |
-565.98% |
-2,549.63% |
Free Cash Flow Firm Growth |
|
821.02% |
0.00% |
4,963.96% |
624.49% |
-180.38% |
-192.12% |
-204.27% |
-349.83% |
26.38% |
-105.95% |
-27.42% |
Invested Capital Growth |
|
-76.17% |
-82.27% |
-95.30% |
-22.44% |
277.35% |
438.44% |
2,181.07% |
80.08% |
53.94% |
164.61% |
125.44% |
Revenue Q/Q Growth |
|
41.57% |
117.43% |
-59.09% |
10.94% |
98.72% |
-10.89% |
-6.38% |
34.90% |
0.17% |
7.77% |
39.64% |
EBITDA Q/Q Growth |
|
107.10% |
-15.21% |
-17.59% |
11.48% |
19.94% |
-90.99% |
-0.84% |
112.42% |
10.47% |
-253.27% |
272.10% |
EBIT Q/Q Growth |
|
107.12% |
-15.21% |
-17.59% |
11.48% |
-1.28% |
-108.16% |
-7.03% |
179.64% |
16.22% |
-327.87% |
214.90% |
NOPAT Q/Q Growth |
|
97.95% |
-22.27% |
2.74% |
-13.61% |
0.72% |
-115.74% |
152.18% |
16.12% |
161.81% |
-344.70% |
225.12% |
Net Income Q/Q Growth |
|
103.60% |
-26.98% |
0.84% |
-11.82% |
-84.37% |
-705.61% |
79.96% |
151.10% |
-910.87% |
-259.70% |
128.40% |
EPS Q/Q Growth |
|
122.22% |
0.00% |
0.00% |
-18.75% |
-92.31% |
-1,500.00% |
85.71% |
150.00% |
-800.00% |
-271.43% |
119.23% |
Operating Cash Flow Q/Q Growth |
|
63.22% |
1,139.35% |
-201.71% |
-20.73% |
43.44% |
-16.37% |
116.99% |
-3,046.89% |
21.74% |
-75.93% |
33.04% |
Free Cash Flow Firm Q/Q Growth |
|
1,748.30% |
7.24% |
18.77% |
-75.02% |
-352.59% |
-22.92% |
-33.42% |
40.14% |
25.56% |
-243.84% |
16.83% |
Invested Capital Q/Q Growth |
|
-76.77% |
-25.25% |
-72.72% |
1,537.42% |
13.03% |
6.66% |
15.55% |
29.27% |
-3.38% |
83.34% |
-1.55% |
Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBITDA Margin |
|
92.92% |
36.24% |
73.00% |
73.35% |
44.27% |
4.48% |
19.56% |
30.80% |
33.97% |
-48.31% |
59.54% |
EBIT Margin |
|
92.91% |
36.23% |
72.99% |
73.34% |
36.43% |
-3.34% |
11.38% |
23.60% |
27.38% |
-57.90% |
47.64% |
Profit (Net Income) Margin |
|
87.09% |
29.25% |
72.09% |
57.30% |
4.51% |
-30.64% |
-5.88% |
2.23% |
-18.02% |
-60.14% |
12.23% |
Tax Burden Percent |
|
96.71% |
94.31% |
109.42% |
85.02% |
16.68% |
59.63% |
1,250.98% |
27.05% |
95.48% |
117.30% |
69.82% |
Interest Burden Percent |
|
96.92% |
85.60% |
90.27% |
91.90% |
74.16% |
1,539.16% |
-4.13% |
34.87% |
-68.92% |
88.55% |
36.78% |
Effective Tax Rate |
|
3.29% |
0.00% |
-9.42% |
14.98% |
27.15% |
0.00% |
0.00% |
72.95% |
0.00% |
0.00% |
30.18% |
Return on Invested Capital (ROIC) |
|
8.97% |
7.64% |
25.76% |
12.62% |
12.19% |
-2.00% |
2.89% |
1.60% |
4.36% |
-7.50% |
7.83% |
ROIC Less NNEP Spread (ROIC-NNEP) |
|
10.25% |
4.57% |
8.43% |
11.77% |
2.31% |
-8.23% |
-0.09% |
0.78% |
-2.37% |
-10.29% |
4.41% |
Return on Net Nonoperating Assets (RNNOA) |
|
0.17% |
0.40% |
0.18% |
2.22% |
1.21% |
-7.20% |
-0.10% |
0.54% |
-1.68% |
-9.13% |
3.97% |
Return on Equity (ROE) |
|
9.14% |
8.03% |
25.93% |
14.84% |
13.40% |
-9.20% |
2.79% |
2.14% |
2.68% |
-16.62% |
11.81% |
Cash Return on Invested Capital (CROIC) |
|
0.00% |
157.22% |
200.07% |
36.93% |
-100.00% |
-125.83% |
-183.01% |
-55.72% |
-41.63% |
-90.40% |
-74.90% |
Operating Return on Assets (OROA) |
|
8.44% |
8.25% |
22.05% |
14.14% |
12.87% |
-1.13% |
4.08% |
5.61% |
6.76% |
-10.75% |
10.40% |
Return on Assets (ROA) |
|
7.91% |
6.66% |
21.78% |
11.05% |
1.59% |
-10.41% |
-2.11% |
0.53% |
-4.45% |
-11.16% |
2.67% |
Return on Common Equity (ROCE) |
|
-1.35% |
-0.02% |
-2.96% |
4.28% |
7.83% |
-9.15% |
2.32% |
2.14% |
2.68% |
-16.65% |
11.71% |
Return on Equity Simple (ROE_SIMPLE) |
|
-95.66% |
0.00% |
-156.94% |
20.15% |
13.85% |
0.00% |
0.08% |
-2.31% |
-4.76% |
0.00% |
-4.24% |
Net Operating Profit after Tax (NOPAT) |
|
10 |
8.02 |
8.24 |
7.12 |
7.17 |
-1.13 |
1.58 |
1.83 |
4.79 |
-12 |
15 |
NOPAT Margin |
|
86.75% |
31.01% |
77.89% |
60.66% |
30.74% |
-5.43% |
7.27% |
6.25% |
16.35% |
-37.12% |
33.26% |
Net Nonoperating Expense Percent (NNEP) |
|
-1.27% |
3.06% |
17.33% |
0.86% |
9.89% |
6.23% |
2.98% |
0.82% |
6.73% |
2.80% |
3.43% |
SG&A Expenses to Revenue |
|
0.13% |
0.00% |
6.89% |
5.83% |
7.31% |
8.61% |
8.89% |
8.72% |
7.40% |
7.63% |
5.93% |
Operating Expenses to Revenue |
|
7.09% |
63.77% |
27.01% |
26.66% |
63.57% |
103.34% |
88.62% |
76.40% |
72.62% |
157.90% |
52.36% |
Earnings before Interest and Taxes (EBIT) |
|
11 |
9.37 |
7.72 |
8.61 |
8.49 |
-0.69 |
2.47 |
6.91 |
8.03 |
-18 |
21 |
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
11 |
9.37 |
7.72 |
8.61 |
10 |
0.93 |
4.25 |
9.02 |
9.96 |
-15 |
26 |
Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Price to Book Value (P/BV) |
|
0.00 |
6.84 |
0.00 |
0.72 |
2.59 |
3.73 |
4.70 |
2.15 |
2.93 |
1.38 |
1.68 |
Price to Tangible Book Value (P/TBV) |
|
0.00 |
6.84 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
6.11 |
8.08 |
5.51 |
6.19 |
Price to Revenue (P/Rev) |
|
21.36 |
4.04 |
3.32 |
1.92 |
6.02 |
9.22 |
10.65 |
6.12 |
7.83 |
5.22 |
5.39 |
Price to Earnings (P/E) |
|
16.98 |
5.88 |
6.19 |
3.55 |
18.40 |
64.30 |
9,417.59 |
0.00 |
0.00 |
0.00 |
0.00 |
Dividend Yield |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Earnings Yield |
|
5.89% |
17.00% |
16.16% |
28.18% |
5.43% |
1.56% |
0.01% |
0.00% |
0.00% |
0.00% |
0.00% |
Enterprise Value to Invested Capital (EV/IC) |
|
5.78 |
3.29 |
12.57 |
0.74 |
1.80 |
2.39 |
2.55 |
1.45 |
2.09 |
1.04 |
1.32 |
Enterprise Value to Revenue (EV/Rev) |
|
21.51 |
4.02 |
3.41 |
3.10 |
7.17 |
10.94 |
12.30 |
7.29 |
9.51 |
7.44 |
7.75 |
Enterprise Value to EBITDA (EV/EBITDA) |
|
14.74 |
5.29 |
5.79 |
5.06 |
14.23 |
26.34 |
46.10 |
33.19 |
47.01 |
104.64 |
34.51 |
Enterprise Value to EBIT (EV/EBIT) |
|
14.80 |
5.29 |
5.78 |
5.06 |
14.99 |
30.11 |
63.05 |
52.64 |
76.02 |
0.00 |
58.29 |
Enterprise Value to NOPAT (EV/NOPAT) |
|
16.33 |
5.67 |
6.26 |
5.54 |
17.55 |
35.00 |
2,552.08 |
127.52 |
297.95 |
0.00 |
83.28 |
Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
17.35 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.63 |
0.56 |
1.75 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Debt to Equity |
|
0.07 |
1.01 |
0.57 |
0.57 |
0.72 |
0.85 |
1.12 |
0.77 |
0.70 |
0.90 |
0.82 |
Long-Term Debt to Equity |
|
0.00 |
1.00 |
0.00 |
0.57 |
0.72 |
0.77 |
1.03 |
0.59 |
0.65 |
0.81 |
0.55 |
Financial Leverage |
|
0.02 |
0.09 |
0.02 |
0.19 |
0.52 |
0.87 |
1.09 |
0.69 |
0.71 |
0.89 |
0.90 |
Leverage Ratio |
|
1.16 |
1.17 |
1.12 |
1.28 |
1.71 |
2.03 |
2.32 |
1.82 |
1.84 |
2.05 |
2.05 |
Compound Leverage Factor |
|
1.12 |
1.01 |
1.01 |
1.18 |
1.27 |
31.30 |
-0.10 |
0.64 |
-1.27 |
1.82 |
0.75 |
Debt to Total Capital |
|
6.52% |
50.12% |
36.22% |
36.33% |
41.70% |
46.01% |
52.91% |
43.42% |
41.19% |
47.36% |
44.98% |
Short-Term Debt to Total Capital |
|
6.52% |
0.07% |
36.22% |
0.16% |
0.00% |
4.29% |
4.46% |
10.08% |
3.22% |
4.78% |
14.92% |
Long-Term Debt to Total Capital |
|
0.00% |
50.05% |
0.00% |
36.17% |
41.70% |
41.72% |
48.46% |
33.33% |
37.97% |
42.58% |
30.06% |
Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
Noncontrolling Interests to Total Capital |
|
129.88% |
1.59% |
190.55% |
0.14% |
0.10% |
0.05% |
0.06% |
0.02% |
-0.02% |
-0.11% |
0.62% |
Common Equity to Total Capital |
|
-36.40% |
48.28% |
-126.77% |
63.53% |
58.19% |
53.94% |
47.03% |
56.57% |
58.83% |
52.75% |
54.40% |
Debt to EBITDA |
|
0.17 |
0.81 |
0.17 |
2.49 |
3.30 |
5.07 |
9.56 |
9.92 |
9.27 |
47.85 |
11.79 |
Net Debt to EBITDA |
|
-3.21 |
-0.05 |
-0.71 |
1.92 |
2.28 |
4.14 |
6.19 |
5.33 |
8.27 |
31.27 |
10.34 |
Long-Term Debt to EBITDA |
|
0.00 |
0.80 |
0.00 |
2.48 |
3.30 |
4.60 |
8.75 |
7.62 |
8.54 |
43.02 |
7.88 |
Debt to NOPAT |
|
0.18 |
0.86 |
0.18 |
2.73 |
4.07 |
6.74 |
528.99 |
38.13 |
58.72 |
-612.43 |
28.44 |
Net Debt to NOPAT |
|
-3.56 |
-0.05 |
-0.77 |
2.10 |
2.81 |
5.50 |
342.84 |
20.46 |
52.41 |
-400.24 |
24.94 |
Long-Term Debt to NOPAT |
|
0.00 |
0.86 |
0.00 |
2.71 |
4.07 |
6.11 |
484.44 |
29.28 |
54.13 |
-550.63 |
19.01 |
Noncontrolling Interest Sharing Ratio |
|
114.82% |
100.29% |
111.42% |
71.13% |
41.56% |
0.54% |
16.87% |
0.10% |
0.05% |
-0.12% |
0.85% |
Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Free Cash Flow to Firm (FCFF) |
|
252 |
270 |
320 |
80 |
-202 |
-249 |
-334 |
-200 |
-149 |
-512 |
-426 |
Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
-12,270.86% |
-14,858.81% |
1,401.30% |
-35,324.72% |
-21,557.08% |
-47,714.70% |
-27,450.38% |
Free Cash Flow to Firm to Interest Expense |
|
0.00 |
6,304.99 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Operating Cash Flow to Interest Expense |
|
0.00 |
399.28 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Operating Cash Flow Less CapEx to Interest Expense |
|
0.00 |
399.28 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Asset Turnover |
|
0.09 |
0.23 |
0.30 |
0.19 |
0.35 |
0.34 |
0.36 |
0.24 |
0.25 |
0.19 |
0.22 |
Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
316.70 |
0.00 |
207.81 |
167.65 |
157.00 |
155.56 |
Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Invested Capital |
|
76 |
56 |
15 |
252 |
285 |
304 |
351 |
454 |
439 |
804 |
792 |
Invested Capital Turnover |
|
0.10 |
0.25 |
0.33 |
0.21 |
0.40 |
0.37 |
0.40 |
0.26 |
0.27 |
0.20 |
0.24 |
Increase / (Decrease) in Invested Capital |
|
-241 |
-262 |
-312 |
-73 |
209 |
247 |
336 |
202 |
154 |
500 |
440 |
Enterprise Value (EV) |
|
436 |
186 |
193 |
186 |
512 |
726 |
896 |
659 |
917 |
833 |
1,043 |
Market Capitalization |
|
433 |
186 |
188 |
115 |
430 |
612 |
776 |
553 |
755 |
585 |
725 |
Book Value per Share |
|
($0.64) |
$1.49 |
($1.06) |
$13.95 |
$2.63 |
$2.59 |
$2.59 |
$4.02 |
$3.46 |
$5.68 |
$4.45 |
Tangible Book Value per Share |
|
($0.64) |
$1.49 |
($1.06) |
($1.14) |
($0.09) |
($0.09) |
($0.05) |
$1.42 |
$1.25 |
$1.42 |
$1.21 |
Total Capital |
|
76 |
56 |
15 |
252 |
285 |
304 |
351 |
454 |
439 |
804 |
792 |
Total Debt |
|
4.92 |
28 |
5.58 |
92 |
119 |
140 |
186 |
197 |
181 |
381 |
356 |
Total Long-Term Debt |
|
0.00 |
28 |
0.00 |
91 |
119 |
127 |
170 |
151 |
167 |
342 |
238 |
Net Debt |
|
-95 |
-1.76 |
-24 |
70 |
82 |
114 |
120 |
106 |
161 |
249 |
312 |
Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.10 |
0.09 |
0.16 |
0.19 |
0.24 |
0.19 |
0.22 |
Net Nonoperating Expense (NNE) |
|
-0.04 |
0.46 |
0.61 |
0.39 |
6.12 |
5.24 |
2.85 |
1.18 |
10 |
7.28 |
9.28 |
Net Nonoperating Obligations (NNO) |
|
4.92 |
28 |
5.58 |
92 |
119 |
140 |
186 |
197 |
181 |
381 |
356 |
Total Depreciation and Amortization (D&A) |
|
0.00 |
0.00 |
0.00 |
0.00 |
1.83 |
1.62 |
1.77 |
2.11 |
1.93 |
3.03 |
5.25 |
Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.13 |
$0.01 |
($0.13) |
($0.02) |
$0.01 |
($0.07) |
($0.26) |
$0.05 |
Adjusted Weighted Average Basic Shares Outstanding |
|
24.81M |
50.37M |
14.13M |
50.51M |
63.35M |
56.95M |
63.03M |
63.85M |
74.69M |
70.76M |
96.19M |
Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.13 |
$0.01 |
($0.14) |
($0.02) |
$0.01 |
($0.07) |
($0.26) |
$0.05 |
Adjusted Weighted Average Diluted Shares Outstanding |
|
24.81M |
50.37M |
14.13M |
50.51M |
63.35M |
57.77M |
63.03M |
67.16M |
74.69M |
70.76M |
97.50M |
Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
18.34M |
0.00 |
11.48M |
62.96M |
63.35M |
63.69M |
63.93M |
74.65M |
74.68M |
96.85M |
96.85M |
Normalized Net Operating Profit after Tax (NOPAT) |
|
11 |
5.61 |
5.18 |
6.54 |
7.39 |
-1.74 |
0.76 |
4.99 |
4.50 |
-11 |
14 |
Normalized NOPAT Margin |
|
88.76% |
21.71% |
49.00% |
55.78% |
31.70% |
-8.39% |
3.51% |
17.05% |
15.35% |
-33.89% |
32.83% |
Pre Tax Income Margin |
|
90.06% |
31.01% |
65.89% |
67.40% |
27.02% |
-51.37% |
-0.47% |
8.23% |
-18.87% |
-51.27% |
17.52% |
Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
EBIT to Interest Expense |
|
0.00 |
218.87 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
NOPAT to Interest Expense |
|
0.00 |
187.34 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
EBIT Less CapEx to Interest Expense |
|
0.00 |
218.87 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
NOPAT Less CapEx to Interest Expense |
|
0.00 |
187.34 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
Dividend Payout Ratio |
|
0.00% |
21.82% |
0.00% |
87.40% |
119.89% |
263.34% |
0.00% |
-23.89% |
-9.49% |
-4.68% |
0.00% |
Augmented Payout Ratio |
|
0.00% |
21.82% |
0.00% |
87.40% |
119.89% |
277.54% |
6,561.95% |
-226.41% |
-107.47% |
-47.78% |
-17.64% |
Key Financial Trends
Abacus Life (NASDAQ: ABL) has shown significant developments over the last four years based on its financial statements through Q1 2025.
Revenue and Profitability Trends:
- Total revenue increased from approximately $11.7 million in Q2 2023 to $44.1 million in Q1 2025, indicating strong top-line growth driven mainly by non-interest income.
- Net income recovered from losses in 2023, with a significant turnaround to a net income of $5.4 million in Q1 2025, compared to losses over prior quarters.
- The company records zero interest income and interest expenses recently, reflecting a possible strategic shift away from traditional interest-bearing activities.
- Net income in full-year 2023 was negative in most quarters, with the worst being Q4 2023 showing a net loss of approximately $6.2 million to common shareholders, reflecting prior periods of operational challenges.
- Gross margins and expense ratios are affected by high non-interest operating expenses, which totaled around $23.1 million in Q1 2025, requiring monitoring for efficiency improvements.
Cash Flow and Liquidity:
- Operating cash flow was negative in early 2024 and Q1 2025, for example, Q1 2025 saw a net cash outflow from operating activities of about $61.6 million, which could pressure liquidity if sustained.
- Investing activities consistently resulted in outflows mainly due to the purchase of investment securities and property, leasehold improvements, and equipment, indicating ongoing investment in growth and infrastructure.
- Financing activities in Q1 2025 resulted in net cash outflow of about $22.9 million due to debt repayments exceeding issuance, suggesting potential tightening of capital structure or deleveraging.
- Cash and cash equivalents increased from $20.6 million in Q2 2023 to $43.8 million by Q1 2025, providing a better liquidity buffer despite negative operational cash flow.
Balance Sheet and Capital Structure:
- Total assets roughly doubled from about $277 million in Q2 2023 to $856 million in Q1 2025, suggesting successful asset growth and expansion.
- Long-term debt increased overall, reaching approximately $238 million in Q1 2025, up from about $91 million in mid-2023, which raises concerns around leverage and interest obligations.
- Retained earnings remained negative but improved from approximately -$34.5 million in Q2 2024 to -$53.3 million in Q1 2025, reflecting accumulated losses but with some progress.
- Goodwill and intangible assets grew significantly, showing acquisitions or investments in intellectual property, contributing heavily to total assets but potentially resulting in impairment risks.
Summary:
Abacus Life has exhibited strong revenue growth with a shift in its income composition towards non-interest income. Despite recent profitability improvement in Q1 2025, the company is still recovering from losses in 2023. Negative operating cash flow presents liquidity risks though balanced by a larger cash position and structural financing activities. Asset growth is considerable, but leverage increase calls for caution about debt management and financial stability.
08/18/25 01:55 PMAI Generated. May Contain Errors.